Stock OPT OPTHEA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Opthea Limited

Equities

OPT

AU000000OPT2

Market Closed - Australian S.E.
Other stock markets
 11:40:06 26/06/2024 am IST 		5-day change 1st Jan Change
0.36 AUD +4.35% Intraday chart for Opthea Limited -2.70% -36.84%
14/06 Opthea Raises AU$171.5 Million via Institutional Placement, Offer; Shares Down 23% MT
12/06 Opthea to Raise $150.4 Million Through Placement, Entitlement Offers MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Opthea A$55.0m (US$36.9m¹) Retail Entitlement Offer Opens
AQ
Opthea Raises AU$171.5 Million via Institutional Placement, Offer; Shares Down 23%
MT
Opthea Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
AQ
Rights Issue: 100 new shares @ 0.4 AUD for 122 existing shares
FA
Opthea to Raise $150.4 Million Through Placement, Entitlement Offers
MT
Opthea Announces Placement and Partially Underwritten Entitlement Offer to Raise up to Approximately A$227.3 million (US$150.0 million¹)
AQ
Opthea To Present at Clinical Trials at the Summit Meeting
AQ
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
AQ
Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
CI
Opthea Completes Enrollments in COAST, ShORe Trials
MT
Opthea Announces Upcoming Presentations at the Retina World Congress 2024
AQ
Opthea : Quarterly Activity Report - Form 6-K
PU
Opthea to Present at the OIS Retina Innovation Summit at ARVO
AQ
Opthea : to Present at the OIS Retina Innovation Summit at ARVO - Form 6-K
PU
Opthea Appoints John Han, PharmD, as VP Medical Affairs
AQ
Opthea to Participate in the 23ʳᵈ Annual Needham Virtual Healthcare Conference 
AQ
Opthea Appoints Sujal Shah to the Board of Directors
AQ
Opthea Limited Announces Board Changes
CI
Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024
AQ
Opthea to Participate in the Leerink Partners Global Biopharma Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OPT Stock
  4. News Opthea Limited